Close Menu

NEW YORK (GenomeWeb) – An assay from Cepheid to detect influenza A and B as well as respiratory syncytial virus has been cleared by the US Food and Drug Administration and granted CLIA waiver, the company said today.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.